Compass Pathways Reports First Quarter 2025 Financial Results and Highlights Progress in Psychedelic Mental Health Therapies Compass Pathways plc (Nasdaq: CMPS), a biotechnology company pioneering innovative treatments for mental health conditions, today released its financial results for the first quarter…
RHÖN-KLINIKUM AG Reports Solid Start to Financial Year 2025 Amid Regulatory and Economic Challenges RHÖN-KLINIKUM AG, one of Germany’s largest private healthcare providers, has begun the 2025 financial year on stable footing, reporting solid performance figures despite ongoing sector challenges…
Definitive Healthcare Reports First Quarter 2025 Financial Results, Surpasses Guidance Despite Revenue Decline Definitive Healthcare Corp. (Nasdaq: DH), a leading provider of healthcare commercial intelligence, today announced financial results for the first quarter ended March 31, 2025. Despite a year-over-year…
AMN Healthcare Reports Strong Q1 2025 Results with Revenue and Earnings Surpassing Expectations AMN Healthcare Services, Inc. (NYSE: AMN), a leading innovator in total talent solutions for healthcare organizations across the U.S., today reported its financial results for the first…
Sangamo Therapeutics to Release First Quarter 2025 Financial Results and Host Earnings Conference Call on May 12 Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a clinical-stage genomic medicine company developing transformative therapies using its proprietary platform technologies, announced today that it will…
Pacific Prime Thailand Honored with AXA Thailand’s 2025 Top International Broker Award In a significant recognition of its dedication to excellence and commitment to strategic partnerships, Pacific Prime Thailand has been awarded the prestigious Top International Broker Award by AXA…
Unlock Agility and Expertise with Oriola Advisory Services’ Interim Solutions In the highly regulated and rapidly evolving pharmaceutical and healthcare sectors, maintaining agility while ensuring access to expert support can be a significant challenge. Whether responding to sudden workforce changes,…
Ardent Health Reports First Quarter 2025 Financial Results Highlighting Revenue Growth and Strong Earnings Momentum Ardent Health Partners, Inc. (NYSE: ARDT), a premier healthcare provider serving rapidly expanding mid-sized urban markets across the United States, today announced its financial and…
Chemed Corporation to Present at the 2025 Bank of America Securities Health Care Conference Chemed Corporation (NYSE: CHE), a leading publicly traded company with two nationally recognized subsidiaries, today announced its participation in the upcoming Bank of America Securities 2025…
CVS Pharmacy: Bringing Personalized Care to Communities with New Small Format Stores In a rapidly evolving health care landscape, one thing remains constant: the importance of trusted, accessible, and personalized pharmacy care. CVS Pharmacy®, the largest retail pharmacy chain in…
Vasomune Therapeutics to Present Late-Breaking Research on AV-001 at the 2025 American Thoracic Society International Conference Vasomune Therapeutics Inc., a clinical-stage biopharmaceutical company developing novel therapeutics to address diseases driven by vascular dysfunction, today announced its participation in the 2025…
Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) reported robust financial and operational results for the first quarter of 2025, underscoring the company’s continued momentum and strategic focus on advancing its late-stage pipeline while reaffirming full-year revenue guidance. The company achieved a…